Follow us:
  1. Home
  2. News
  3. Health News
  4. Coronavirus News

Coronavirus News

Type 2 diabetes drug may reduce risk of severe COVID-19 cases

Experts say the drugs were associated with a lower risk of death and hospitalization

A new study conducted by researchers from Penn State found that a class of diabetes and obesity drugs may protect diabetics from contracting severe cases of COVID-19. 

According to their findings, diabetics who were taking glucagon-like peptide-1 receptor drugs (GLP-1R) up to six months prior to contracting COVID-19 were more likely to have better outcomes. They had a lower mortality risk, were less likely to be hospitalized, and were less likely to have respiratory issu...

Not sure how to choose?

Get expert buying tips about Coronavirus News delivered to your inbox.

    By entering your email, you agree to sign up for consumer news, tips and giveaways from ConsumerAffairs. Unsubscribe at any time.

    Thank you, you have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.

    Recent Articles

    Sort by: